Clinical Trials Directory

Trials / Completed

CompletedNCT00004559

Fatty Acid Antiarrhythmia Trial (FAAT)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
National Heart, Lung, and Blood Institute (NHLBI) · NIH
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To determine if the dietary N-3 class of polyunsaturated fatty acids (PUFAs) provided in the diet largely from marine fish oils would prevent fatal ventricular tachycardia (VT) or ventricular fibrillation (VF).

Detailed description

BACKGROUND: Sudden death is a common manifestation of ischemic heart disease and therefore of great public health concern. Unfortunately several promising antiarrhythmic drugs proved not to be effective in preventing sudden deaths. This project would test whether a relatively inexpensive and presumably innocuous therapy, fish oil supplements, can prevent life-threatening arrhythmias. There is ample basic evidence that n-3 fatty acids contained in fish oil supplements may suppress arrhythmias, and a clinical trial seems warranted. DESIGN NARRATIVE: Prospective, randomized, placebo-controlled, double-blind. Patients were randomized to 4 grams per day of a PUFA fish oil supplement versus an olive oil placebo. The number of therapeutic discharges were recorded from the ICDs and then confirmed from the recorded electrocardiogram strips with the kinds of arrhythmias which had induced the ICD response. The primary end point, time to first ICD event for ventricular tachycardia or fibrillation (VT or VF) confirmed by stored electrograms or death from any cause, was analyzed by intention to treat. The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.

Conditions

Interventions

TypeNameDescription
BEHAVIORALdietary polyunsaturated fatty acid

Timeline

Start date
1999-03-01
Completion
2002-02-01
First posted
2000-02-10
Last updated
2016-03-16

Source: ClinicalTrials.gov record NCT00004559. Inclusion in this directory is not an endorsement.